Non-Extending Helper Oligonucleotide for Nucleic Acid Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid amplification and detection methods, such as PCR, face challenges in achieving efficient and sensitive detection of target nucleic acids, particularly for low copy numbers, due to limitations in primer binding and secondary structure stability.

Innovation Solution

The use of a non-extending helper oligonucleotide that anneals to the target nucleic acid but does not extend, reducing the Gibbs Free Energy of the secondary structure and enhancing primer accessibility, thereby improving amplification efficiency and sensitivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If standard PCR amplification is used, then amplification can be performed, but amplification efficiency is insufficient for detecting low copy numbers of target nucleic acid

Engineering Contradiction:
Improvedetection sensitivityVSAvoidamplification efficiency
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent introduces a non-extending helper oligonucleotide as an intermediary component that binds to the target nucleic acid and facilitates primer binding. This helper oligonucleotide acts as a mediator that enhances the interaction between the primer and target, thereby improving amplification efficiency and detection sensitivity for low copy number targets without interfering with the standard PCR process

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the Gibbs Free Energy of the secondary structure by introducing the non-extending helper oligonucleotide, which changes the thermodynamic parameters of the reaction system. This parameter change optimizes the binding affinity and stability of the primer-target complex, enabling more efficient amplification of low copy number targets

Inventive Principle:
Principle #35Parameter changes

2Productivity

If primers are used for amplification, then nucleic acid can be amplified, but primer accessibility to target nucleic acid is limited by secondary structure stability

Engineering Contradiction:
Improveamplification efficiencyVSAvoidsecondary structure stability
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The non-extending helper oligonucleotide serves as an intermediary that binds to the target nucleic acid in regions that may be obscured by secondary structures. By occupying these regions and stabilizing the target conformation, the helper oligonucleotide makes the primer binding sites more accessible, thereby improving amplification efficiency without requiring changes to the primer design or reaction conditions

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach leads to increased accumulation of PCR products and improved sensitivity, enabling the detection of small amounts of target nucleic acid, even in complex samples, by facilitating primer binding and extension.

Implementation Method 1

reducing the Gibbs Free Energy of the secondary structure and enhancing primer accessibility

Methodology Applied
Scientific EffectGibbs Free Energy reduction:

Implementation Method 2

a non-extending helper oligonucleotide that anneals to the target nucleic acid but does not extend

Methodology Applied
Scientific EffectAnnealing: Annealing

Implementation Method 3

PCR utilizes a polymerase enzyme

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentEP3494227B1Helper oligonucleotide for improving efficiency of amplification and detection/quantitation of nucleic acids
Publication Date: 2024.12.11 ROCHE DIAGNOSTICS GMBH
  • EP3494227B1 patent drawingFigure 1
  • EP3494227B1 patent drawingFigure 2
  • EP3494227B1 patent drawingFigure 3

AI summary

Improved methods for the detection and quantitation of a target nucleic acid in a sample using a non-extending helper oligonucleotide are described. The methods include contacting nucleic acids in a sample with amplification reagents including one or more primers, one or more non-extending helper oligonucleotides, and one or more probes. The non-extending helper oligonucleotide facilitates and increases the target nucleic acid accessibility of one or more of the primers, result in greater accumulation of amplicon production, thereby increasing the efficiency and sensitivity of the amplification assay, including amplification assays for Hepatitis C Virus (HCV), for example, HCV Genotype 5. Kits, articles of manufacture, and reaction mixtures are also provided.